BAXTER HOMECHOICE AUTOMATED PERITONEAL DIALYSIS SYSTEM FULL- SCALE LAUNCH
This article was originally published in The Gray Sheet
Executive Summary
BAXTER HOMECHOICE AUTOMATED PERITONEAL DIALYSIS SYSTEM FULL- SCALE LAUNCH in the U.S., Japan and Western Europe is planned for July. Cleared via 510(k) in March and available in Canada since November, the system currently is in limited release in the U.S., Japan, and West Europe while Baxter gears up production for the full commercial introduction and fine-tunes software features. The limited U.S. release involves six dialysis centers and about 40 patients; about 150 patients worldwide are using the system, according to Baxter.
You may also be interested in...
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.